Overview

Intranasal Dexmedetomidine VS Oral Chloral Hydrate for Rescue Sedation During Magnetic Resonance Imaging

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this investigation was to test the hypothesis that intranasal dexmedetomidine is as effective as second dose of oral chloral hydrate for rescue sedation in infant age between 1 and 6 months who were not adequately sedated following initial dose of chloral hydrate.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Guangzhou Women and Children's Medical Center
Treatments:
Chloral Hydrate
Dexmedetomidine
Criteria
Inclusion Criteria:

- 160 children of ASA physical status I or II, aged between 1 and 6 months, failed
chloral hydrate sedation during MRI scanning

Exclusion Criteria:

- known allergy or hypersensitive reaction to dexmedetomidine or CH, organ dysfunction,
pneumonia, acute upper respiratory airway inflammation, preterm, cardiac arrhythmia or
and congenital heart disease.